… aspects should ideally be considered as early as the drug development stage, for example, by designing active substances that are more degradable in sewage treatment … a responsible approach to the use of medicines, starting with adapted prescribing practices in medical practices, promoting a healthier lifestyle, and ensuring the …

… 2024 (1). The guideline: specifies which medicinal products require an ERA. For example, herbal substances, vitamins, and amino acids are exempt. describes the … by the EMEA guideline, must also be complete and conducted in accordance with Good Laboratory Practice (GLP). However, it is also permissible to submit literature data instead of …

… can be problematic from an environmental perspective, such as high stability or good water solubility. Substances with so-called PBT properties are considered … Environment Agency 2025: Toxicity of active substances to aquatic organisms - examples from aquatics with indication of the most sensitive species Toxicity of …

… pharmaceutical substances from entering the wastewater. This also applies, for example, to used tissues after using nasal drops or ointments. Another pathway for … economically sensible to implement avoidance measures in medical and pharmaceutical practices. Solely upgrading sewage treatment plants will not suffice to meet the …

… the pharmacy's sales area. Other suitable locations for the poster include medical practices, hospitals, health advisory centres, health insurance providers, and waste … pharmacy staff with detailed background knowledge for such conversations. It offers practical suggestions on how pharmacists can contribute to environmentally …

… slide set and accompanying texts, this topic can be taught in a comprehensive and practice-oriented manner, even within tight curricula. last update on 16.12.2024 … solutions along the pharmaceutical life cycle, extending into clinical practice and everyday pharmacy operations. Specifically, the slide set covers a …

… for systematically integrating environmental considerations into everyday pharmacy practice while ensuring the best possible patient care. By incorporating … that they apply this knowledge in collaboration with the medical profession. For example, it would be beneficial if pharmacists could, when possible, offer advice on …

… / Adobe Stock By integrating environmentally conscious approaches into prescribing practices, doctors can actively help reduce the entry of pharmaceuticals into the … without disadvantages. For example, in mild cases of sleep disorders, recommending good sleep hygiene practices—such as maintaining a regular sleep schedule and …

… waste, not in the toilet, to prevent pharmaceuticals from entering wastewater. For example, if you have applied a medicinal ointment, first wipe your hands with a … have shown that some of these substances have negative environmental effects. For example, feminisation of male fish has been observed downstream of sewage treatment … plant effluents due to exposure to hormonally active pharmaceuticals. Another example is the painkiller diclofenac, which has been detected in water bodies and …

… can help prevent the negative environmental effects of pharmaceuticals. For example, disease prevention, considering non-medicinal treatments, and the … In some cases, non-medicinal therapies can be an effective option. Here are some examples: Physiotherapy: For muscular complaints or injuries, physiotherapy can be …

… environments. last update on 20.01.2025 Medicines are essential tools in medical practice and are omnipresent in our daily lives. We all take medications as needed … designed to interfere with the regulatory mechanisms of organisms. They can, for example, influence metabolism, disrupt hormonal balance, or alter cell-to-cell …

… transition - promising funding mechanisms, and relevant aspects on Science Policy Practice Interaction (SPPI) and interviews with National Key Stakeholders. Also, … and Sustainability Research and Innovation needs, Funding and Science Policy and Practice Interactions - CASRI Deliverable 2.1. ) National Reviews and Stakeholder …